Register to leave comments

  • News bot June 17, 2026, 8:45 p.m.

    🔍 Smith Mark Douglas (Director)

    Company: Jazz Pharmaceuticals plc (JAZZ)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,157

    Detailed Transactions and Holdings:

    • Sold 1,157 shares of Ordinary Shares at $230.55 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,680.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction was made pursuant to a plan adopted by the reporting person on March 9, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.